Skip to content

    Recently Viewed

      Listening...

      Home / Latest news / Caring & giving /
      Why Johnson & Johnson has made it a mission to improve surgical care in Africa
      African Doctors

      Why Johnson & Johnson has made it a mission to improve surgical care in Africa

      As the G4 Alliance plans to discuss safe and affordable surgical care at the 70th annual World Health Assembly this week, a leader at the company, fresh off a trip to the continent, shares why it’s a topic that resonates at Johnson & Johnson.

      Share Article
      share to

      A few weeks ago, I had the unique privilege of traveling to Africa to meet with Johnson & Johnson employees, government officials and other stakeholders in Accra, Ghana, and Johannesburg, South Africa.

      While I travel frequently, it is always a great experience to see the work of our international employees and partners firsthand, and to see our company Credo in action. My visit to one of those partners, the Medical & Surgical Skills Institute (MSSI) in Ghana, was one of the highlights of my trip.

      Suturing class

      Participants in a suturing class in Ghana

      According to data from Vanderbilt University Medical Center, 5 billion people—particularly in low-income and lower-middle-income countries—lack access to safe, affordable surgical and anesthesia care. And while Ghana, on average, does better than most countries in making surgery available to people who need it, it’s always crucial to keep training new health workers to help maintain the skills of people working in surgical settings.

      In fact, ensuring that more people around the world have access to essential surgical care is a major component of Johnson & Johnson’s commitment to the 2030 UN Sustainable Development Goals.

      To date, more than 10,500 healthcare providers have received critical skills training from MSSI, which gets supplies and funding from Johnson & Johnson.

      A commitment to help improve surgical training in Africa

      For more than 10 years, the company has partnered with MSSI to provide life-saving surgical training to doctors, nurses and other healthcare providers in Ghana and throughout sub-Saharan Africa. To date, more than 10,500 healthcare providers have received critical skills training from MSSI, which gets supplies and funding from Johnson & Johnson.

      During my visit, I was able to observe a suturing class for nurses and midwives who came from all over Ghana, including many rural areas outside the capital of Accra. Their commitment to learning was clear: They were excited to improve their skills in a hospital setting, and looked forward to returning home to better serve their patients and share what they’d mastered alongside other nurses and midwives.

      All over the world, the Credo is a force for good, driving us to ensure we make a difference in the communities in which we work around the world. My trip confirmed for me that Johnson & Johnson has an exciting opportunity to grow in sub-Saharan Africa and meet the significant burgeoning surgical—and overall healthcare—needs there for years to come.

      More from Johnson & Johnson

      Latest news
      Q1 2024-1x1.png

      What you need to know about Johnson & Johnson’s 2024 first-quarter earnings

      Here’s an infographic breakdown of the company’s first-quarter earnings results, including key highlights from its Innovative Medicine and MedTech businesses.
      Latest news
      healthcare worker in protective medical gear

      Johnson & Johnson named to Fortune’s 2024 America’s Most Innovative Companies list

      The company’s drive to develop novel solutions for the world’s toughest healthcare challenges has earned it a spot on Fortune’s second annual list.
      Innovation
      Headshots of three Johnson and Johnson female scientists

      Meet 3 leaders who are breaking new ground for women in healthcare

      For International Women’s Day, celebrate the achievements of these amazing female scientists and researchers at Johnson & Johnson.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.